University of Giessen, official name Justus Liebig University Giessen, is a large public research university in Giessen, Hesse, Germany. It is named after its most famous faculty member, Justus von Liebig, the founder of modern agricultural chemistry and inventor of artificial fertiliser.

During the past decade, University of Giessen conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Giessen" #1 sponsor was "University of Giessen" with 6 trials, followed by "IntraBio Inc" with 4 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Ottawa Heart Institute Research Corporation" with 1 trials sponsored and "Somahlution LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Giessen" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Comenius University" with 1 trials as a collaborator, "Else Kröner-Fresenius Stiftung, Bad Homburg, Germany" with 1 trials as a collaborator, "Hannover Medical School" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "University of Giessen" are "Coronary Artery Disease" (3 trials), "Niemann-Pick Disease, Type C" (2 trials), "Pulmonary Hypertension" (2 trials), "Acute Mountain Sickness" (1 trials) and "Ataxia Telangiectasia" (1 trials). Many other conditions were trialed in "University of Giessen" in a lesser frequency.

Most popular intervention types in "University of Giessen" are "Drug" (6 trials), "Other" (5 trials), "Device" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "IB1001" (3 trials), "Aerobic endurance training intervention" (1 trials), "BSF 208075" (1 trials), "Breathing procedure 1" (1 trials) and "Breathing procedure 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Giessen" are 15 trials for "All" genders.

Currently, there are NaN active trials in "University of Giessen". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University of Giessen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Giessen, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".